AI Technology Group Moves Forward with Acquisition of AVM Biotechnology

October 11, 2025 - 02:39

RENO, Nev., Oct. 10, 2025 — AI Technology Group Inc. has taken a significant step in its growth strategy by signing a definitive agreement to acquire AVM Biotechnology Inc. This agreement, dated July 31, 2025, marks a pivotal moment for the Company as it aims to enhance its portfolio in the biotechnology sector.

As part of the acquisition process, a newly formed subsidiary of AI Technology Group will merge with AVM, allowing AVM to operate as a wholly owned subsidiary upon the completion of the transaction. This merger is contingent upon customary closing conditions, which are standard in such agreements.

The move underscores AI Technology Group's commitment to expanding its capabilities and offerings in the rapidly evolving field of biotechnology. By integrating AVM's innovative technologies and expertise, the Company seeks to strengthen its position in the market and drive future growth. This acquisition is expected to create significant opportunities for both entities as they work together to advance their respective missions.